Is a complete PAVM research report available?

No complete published report is available for PAVmed Inc. (PAVM) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

PAVmed Inc. (PAVM)

NASDAQ: PAVM · USD

$5.06

-0.04 (-0.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first PAVM analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	36.2M
Revenue (ttm)	85K
Net income (ttm)	-28.5M
EPS (ttm)	-$30.0
Shares out	7.2M
Volume	2,703
Beta	0.55
Price target	$36.0	+612.2%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 85K
Net income (ttm): -28.5M
EPS (ttm): -$30.0
Market cap: 36.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PAVM indicators

Market & fundamental data

Available fields

203

Groups with data

Currency

USD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001624326
Company name	PAVmed Inc.
Country	United States
Country code	US
Cusip	70387R502
Employees	41
Employees Change	2%
Employees Change Percent	5.13
Enterprise value	$46.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	41
Industry PE Fwd	19.92
IPO Date	2016-04-28
Isin	US70387R5028
Last refreshed	2026-07-31
Market cap	$36.2M
Market cap category	Nano-Cap
Price	$5.06
Price currency	USD
Rev Per Employee	2,073.17x
Sector	Healthcare
Sector PE	45.56
Sector PE Fwd	24.38
Sic	3841
Symbol	PAVM
Website	https://www.pavmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-78.63%
EV Sales Forward	108.07x
EV/Sales	545.42x
FCF yield	-17.39%
P/B ratio	0.89x
P/S ratio	425.76x
PS Forward	84.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-28,702.35%
EBITDA Margin	-28,605.88%
Gross margin	-228.24%
Gross Profit	$-194,000
Net Income	$-28.5M
Net Income Growth Years	0%
Pretax Margin	-26,065.88%
Profit Per Employee	$-694,073
ROA	-31.04
Roa5y	-73.92
ROCE	-58.43
ROE	-67.22
ROIC	-33.08

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-50.35%
Cagr1y	-70.84%
Cagr3y	-67.31%
Cagr5y	-71.67%
EPS Growth Years	0
Revenue Growth	-95.74x
Revenue Growth Q	175x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	-48.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$45.4M
Cash	$6.8M
Current Assets	$7.4M
Current Liabilities	$3.7M
Debt	$17M
Debt Equity	$0.68
Equity	$25M
Interest Coverage	-1,219.9
Liabilities	$20.4M
Long Term Assets	$38M
Long Term Liabilities	$16.8M
Net Cash	$-10.2M
Net Cash By Market Cap	$-28.1
Net Debt Equity	$0.41
Tangible Book Value	$35.8M
Tangible Book Value Per Share	$5.7
WACC	4.97

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.02
Inventory Turnover	1.12
Net Working Capital	$-2.5M
Quick ratio	1.87
Working Capital	$3.8M
Working Capital Turnover	$-0.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	62.56%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.91%
1Y total return	-70.81%
200-day SMA	8.75
3Y total return	-96.51%
50-day SMA	5.46
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.82%
All Time High	6,858
All Time High Change	-99.93%
All Time High Date	2016-08-04
All Time Low	3.85
All Time Low Change	31.3%
All Time Low Date	2026-06-18
ATR	0.53
Beta	0.55
Beta1y	0.36
Beta2y	1.39
Ch YTD	-23.69
High	5.23
High52	28.44
High52 Date	2026-01-21
High52ch	-82.23%
Low	4.97
Low52	3.85
Low52 Date	2026-06-18
Low52ch	31.3%
Ma50ch	-7.45%
Price vs 200-day SMA	-42.21%
RSI	44.93
RSI Monthly	31.82
RSI Weekly	34.43
Sharpe ratio	-0.43x
Sortino ratio	-0.79
Total Return	62.56%
Tr YTD	-23.69
Tr1m	-5.69%
Tr1w	11.35%
Tr3m	-43.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	0
Analyst Ratings	Buy
Earnings EPS Estimate	$-0.64
Earnings Revenue Estimate	48,000x
Earnings Revenue Estimate Growth	700x
Operating Income	$-24.4M
Operating margin	-28,700
Price target	$36
Price Target Change	$612

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,197,015%
Float Percent	72.59%
Net Borrowing	3,851,000
Shares Insiders	20.13%
Shares Institutions	1.91%
Shares Out	7,159,034
Shares Qo Q	76.58%
Shares Yo Y	-62.56%
Short Float	0.53%
Short Ratio	1.19
Short Shares	0.38

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-9.7M
Adjusted OCF	-9,610,000
Average Volume	13,182.7x
Bv Per Share	5.7
CAPEX	$-47,000
Ch10y	-99.92
Ch1m	-5.69
Ch1w	11.35
Ch1y	-70.81
Ch3m	-43.33
Ch3y	-96.99
Ch5y	-99.84
Ch6m	-33.83
Change	-0.88%
Change From Open	-2.03
Close	5.1
Days Gap	1.18
Depreciation Amortization	82,000
Dollar Volume	13,663.9
Earnings Date	2026-08-13
Earnings Time	bmo
EBIT	$-24.4M
EBITDA	$-24.3M
EPS	$-29.95
F Score	2
FCF	$-6.3M
FCF EV Yield	-13.57x
FCF Per Share	$-0.88
Financing CF	10,052,000
Fiscal Year End	December
Founded	2,014
Investing CF	-47,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2026-01-02
Last Split Type	Reverse
Last10k Filing Date	2026-03-27
Ma150	7.86
Ma150ch	-35.68%
Ma20	5.4
Ma20ch	-6.46%
Net CF	3,760,000
Next Earnings Date	2026-08-13
Open	5.16
Optionable	Yes
Position In Range	32.73
Ppne	1,951,000
Price Date	2026-07-30
Ptbv Ratio	1.01
Relative Volume	0.21x
Revenue	85,000x
SBC By Revenue	3,958.82x
Share Based Comp	3,365,000
Tr6m	-33.83%
Us State	New York
Volume	2,703
Z Score	-9.33

PAVmed Inc. (PAVM)

Coverage state: Market snapshot only — no published research

Generate the first PAVM analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · PAVM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PAVM indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PAVM

Frequently asked questions